Implementation support for contingency management: preferences of opioid treatment program leaders and staff.

Contingency management Implementation support Opioid use disorder

Journal

Implementation science communications
ISSN: 2662-2211
Titre abrégé: Implement Sci Commun
Pays: England
ID NLM: 101764360

Informations de publication

Date de publication:
30 Apr 2021
Historique:
received: 18 09 2020
accepted: 20 04 2021
entrez: 1 5 2021
pubmed: 2 5 2021
medline: 2 5 2021
Statut: epublish

Résumé

Contingency management (CM), a behavioral intervention that provides incentives for achieving treatment goals, is an evidence-based adjunct to medication to treat opioid use disorder. Unfortunately, many front-line treatment providers do not utilize CM, likely due to contextual barriers that limit effective training and ongoing support for evidence-based practices. This study applied user-informed approaches to adapt a multi-level implementation strategy called the Science to Service Laboratory (SSL) to support CM implementation. Leaders and treatment providers working in community-based opioid treatment programs (OTPs; N = 43) completed qualitative interviews inquiring about their preferences for training and support implementation strategies (didactic training, performance feedback, and external facilitation). Our team coded interviews using a reflexive team approach to identify common a priori and emergent themes. Leaders and providers expressed a preference for brief training that included case examples and research data, along with experiential learning strategies. They reported a desire for performance feedback from internal supervisors, patients, and clinical experts. Providers and leaders had mixed feelings about audio-recording sessions but were open to the use of rating sheets to evaluate CM performance. Finally, participants desired both on-call and regularly scheduled external facilitation to support their continued use of CM. This study provides an exemplar of a user-informed approach to adapt the SSL implementation support strategies for CM scale-up in community OTPs. Study findings highlight the need for user-informed approaches to training, performance feedback, and facilitation to support sustained CM use in this setting.

Sections du résumé

BACKGROUND BACKGROUND
Contingency management (CM), a behavioral intervention that provides incentives for achieving treatment goals, is an evidence-based adjunct to medication to treat opioid use disorder. Unfortunately, many front-line treatment providers do not utilize CM, likely due to contextual barriers that limit effective training and ongoing support for evidence-based practices. This study applied user-informed approaches to adapt a multi-level implementation strategy called the Science to Service Laboratory (SSL) to support CM implementation.
METHODS METHODS
Leaders and treatment providers working in community-based opioid treatment programs (OTPs; N = 43) completed qualitative interviews inquiring about their preferences for training and support implementation strategies (didactic training, performance feedback, and external facilitation). Our team coded interviews using a reflexive team approach to identify common a priori and emergent themes.
RESULTS RESULTS
Leaders and providers expressed a preference for brief training that included case examples and research data, along with experiential learning strategies. They reported a desire for performance feedback from internal supervisors, patients, and clinical experts. Providers and leaders had mixed feelings about audio-recording sessions but were open to the use of rating sheets to evaluate CM performance. Finally, participants desired both on-call and regularly scheduled external facilitation to support their continued use of CM.
CONCLUSIONS CONCLUSIONS
This study provides an exemplar of a user-informed approach to adapt the SSL implementation support strategies for CM scale-up in community OTPs. Study findings highlight the need for user-informed approaches to training, performance feedback, and facilitation to support sustained CM use in this setting.

Identifiants

pubmed: 33931126
doi: 10.1186/s43058-021-00149-2
pii: 10.1186/s43058-021-00149-2
pmc: PMC8088083
doi:

Types de publication

Journal Article

Langues

eng

Pagination

47

Subventions

Organisme : NIDA NIH HHS
ID : R01DA046941
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20GM125507
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM125507
Pays : United States
Organisme : NIDA NIH HHS
ID : K23 DA050729
Pays : United States
Organisme : NIAAA NIH HHS
ID : T32AA007459
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA046941
Pays : United States

Références

J Soc Serv Res. 2011 Jul 1;37(4):390-402
pubmed: 21927521
BMC Health Serv Res. 2019 Jul 9;19(1):466
pubmed: 31288797
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Implement Sci. 2018 Feb 22;13(1):35
pubmed: 29471849
Addiction. 2011 Feb;106(2):428-41
pubmed: 20925684
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
Prof Psychol Res Pr. 2020 Apr;51(2):134-144
pubmed: 32982034
Arch Gen Psychiatry. 2002 Sep;59(9):817-24
pubmed: 12215081
Drug Alcohol Depend. 2012 Mar 1;121(3):205-12
pubmed: 21925807
Subst Abus. 2018;39(2):211-217
pubmed: 29522381
J Psychoactive Drugs. 2013 Jan-Mar;45(1):17-27
pubmed: 23662328
Drug Alcohol Depend. 2010 Jun 1;109(1-3):167-74
pubmed: 20149950
JMIR Res Protoc. 2019 Oct 9;8(10):e14990
pubmed: 31599736
Drug Alcohol Depend. 2000 Feb 1;58(1-2):55-66
pubmed: 10669055
Cogn Behav Pract. 2014 Feb;21(1):1-11
pubmed: 25382963
J Subst Abuse Treat. 2014 Apr;46(4):429-38
pubmed: 24462242
Adm Policy Ment Health. 2011 Jul;38(4):238-53
pubmed: 21190075
Harv Rev Psychiatry. 2015 Mar-Apr;23(2):63-75
pubmed: 25747920
Subst Abus. 2011 Oct;32(4):180-90
pubmed: 22014248
Implement Sci. 2017 Sep 29;12(1):117
pubmed: 28962632
Drug Alcohol Depend. 2007 Mar 16;87(2-3):107-18
pubmed: 17023123
J Subst Abuse Treat. 2002 Sep;23(2):81-6
pubmed: 12220605
J Consult Clin Psychol. 2005 Feb;73(1):106-15
pubmed: 15709837
BMC Psychol. 2015 Sep 16;3:32
pubmed: 26376626
Clin Psychol (New York). 2010 Mar;17(1):1-30
pubmed: 20877441
Transl Behav Med. 2019 Nov 25;9(6):1057-1064
pubmed: 30535343
J Public Health Dent. 2011 Winter;71(s1):S52-S63
pubmed: 21499543
Psychiatrist. 2011 May;35(5):161-163
pubmed: 22558006
Clin Psychol (New York). 2016 Jun;23(2):180-200
pubmed: 29456295
Nurse Educ Today. 2004 Feb;24(2):105-12
pubmed: 14769454
J Subst Abuse Treat. 2018 Dec;95:26-34
pubmed: 30352667
J Subst Abuse Treat. 2008 Apr;34(3):293-301
pubmed: 17600652
Int J Nurs Stud. 2010 Nov;47(11):1451-8
pubmed: 20598692
J Subst Abuse Treat. 2000 Sep;19(2):117-26
pubmed: 10963923
J Subst Abuse Treat. 2012 Mar;42(2):134-42
pubmed: 22154040
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
J Behav Health Serv Res. 2017 Apr;44(2):177-194
pubmed: 26289563
J Clin Psychol. 2010 Jan;66(1):73-95
pubmed: 19899142
Subst Abus. 2016;37(1):134-40
pubmed: 26682582

Auteurs

Kelli Scott (K)

Center for Alcohol and Addiction Studies, Brown University School of Public Health, 121 South Main Street, Providence, RI, 02903, USA. kelli_scott@brown.edu.

Shelly Jarman (S)

Center for Alcohol and Addiction Studies, Brown University School of Public Health, 121 South Main Street, Providence, RI, 02903, USA.

Samantha Moul (S)

University of New Haven, 300 Boston Post Road, West Haven, CT, 06516, USA.

Cara M Murphy (CM)

Center for Alcohol and Addiction Studies, Brown University School of Public Health, 121 South Main Street, Providence, RI, 02903, USA.

Kimberly Yap (K)

Center for Alcohol and Addiction Studies, Brown University School of Public Health, 121 South Main Street, Providence, RI, 02903, USA.

Bryan R Garner (BR)

RTI International, 3040 E Cornwallis Rd, Durham, NC, 27709, USA.

Sara J Becker (SJ)

Center for Alcohol and Addiction Studies, Brown University School of Public Health, 121 South Main Street, Providence, RI, 02903, USA.

Classifications MeSH